Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Aclidinium bromide
Placebo
Locations
120
United States
Almirall Investigational Sites#926
Jasper, Alabama, United States
Almirall Investigational Sites#858
Ozark, Alabama, United States
Almirall Investigational Sites#900
Phoenix, Arizona, United States
Almirall Investigational Sites#899
Tucson, Arizona, United States
Almirall Investigational Sites#855
Tucson, Arizona, United States
Almirall Investigational Sites#879
Little Rock, Arkansas, United States
Start Date
August 1, 2006
Primary Completion Date
June 1, 2008
Completion Date
June 1, 2008
Last Updated
January 4, 2017
NCT07509606
NCT07477600
NCT07382258
NCT07195838
NCT06595784
NCT06714721
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions